Category
CAS Number
Metolazone - 17560-51-9 : IMP - A - 50869-25-5 : IMP - B - 28508-63-6 : IMP - C - 28524-40-5 : IMP - D - 4015-23-0 : IMP - E - 23380-54-3 :
Molecular Formula
Metolazone - C16H16ClN3O3S : IMP - A - C16H16ClN3O3S : IMP - B - C16H16ClN3O3S : IMP - C - C15H14ClN3O3S : IMP - D - C16H14ClN3O3S : IMP - E - C14H14ClN3O3S
Molecular Weight
Metolazone - 365.8 g/mol : IMP - A - 365.83 g/mol : IMP - B - 365.83 g/mol : IMP - C - 351.81 g/mol : IMP - D - 363.82 g/mol : IMP - E - 339.8 g/mol
Synonym

Metolazone - (2RS)-7-Chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide; -Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide; 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone; 7-Chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide; 6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide ;

Metolazone EP Impurity A - (2RS)-7-Chloro-2-methyl-3-(3-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulphonamide ; 7-Chloro-2-methyl-3-(3-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide ;

Metolazone EP Impurity B - 7-chloro-2-methyl-4-oxo-3-(p-tolyl)-1, 2, 3, 4-tetrahydroquinazoline-6-sulfonamide ; (2RS)-7-Chloro-2-methyl-3-(4-methylphenyl)-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulphonamide ;

Metolazone EP Impurity C - (2RS)-7-chloro-2-methyl-4-oxo-3-phenyl1,2,3,4-tetrahydroquinazoline-6-sulfonamide ; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-phenyl-6-quinazolinesulfonamide;

Metolazone EP Impurity D - 7-Chloro-2-methyl-3-(2-methylphenyl)-4-oxo-3,4-dihydroquinazoline-6-sulfonamide; 6-Quinazolinesulfonamide, 7-chloro-3,4-dihydro-2-methyl-3-(2-methylphenyl)-4-oxo-;

Metolazone EP Impurity E - 2-Amino-4-chloro-N-(2-methylphenyl)-5-sulfamoylbenzamide ; Metolazone USP Related Compound B ; Metolazone benzamide analog; 2-amino-5-(aminosulfonyl)-4-chloro-N-(2-methylphenyl)- ;

slide_1